• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleosides Pyrimidine nucleosides
• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleosides

Comprehensive Analysis of 1-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,3,4-tetrahydropyrimidine-2,4-dione (CAS No. 688007-27-4)

The compound 1-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,3,4-tetrahydropyrimidine-2,4-dione (CAS No. 688007-27-4) is a structurally unique molecule that has garnered significant attention in the fields of medicinal chemistry and biochemistry. Its complex name reflects its intricate molecular architecture, which combines a dihydroxyoxolane moiety with a tetrahydropyrimidine-2,4-dione core. This combination of functional groups makes it a subject of interest for researchers exploring novel bioactive compounds, particularly in the context of nucleoside analogs and glycosylation studies.

In recent years, the scientific community has shown growing interest in nucleoside derivatives due to their potential applications in drug development and biotechnology. The presence of the hydroxymethyl group in this compound suggests possible reactivity in glycosidic bond formation, a key feature in the synthesis of antiviral and anticancer agents. Researchers are particularly intrigued by its potential role in modulating enzyme-substrate interactions, which could lead to breakthroughs in targeted therapies.

The oxolan-2-yl component of this molecule is structurally similar to sugar moieties found in many natural products, making it a valuable scaffold for structure-activity relationship studies. This characteristic has led to investigations into its potential as a bioisostere for natural nucleosides, with particular relevance to RNA interference technologies and epigenetic modulation. These areas represent some of the most cutting-edge research in molecular biology today.

From a synthetic chemistry perspective, the tetrahydropyrimidine-2,4-dione core presents interesting challenges and opportunities. This heterocyclic system is known for its diverse biological activities, and its incorporation into more complex structures like this compound opens new avenues for drug discovery. The compound's solubility profile, influenced by its multiple hydroxy groups, makes it particularly interesting for formulation scientists working on biopharmaceutical delivery systems.

In the context of current research trends, this compound aligns with several hot topics in medicinal chemistry, including fragment-based drug design and metabolite-inspired synthesis. Its structural features make it a potential candidate for high-throughput screening libraries, especially in programs targeting nucleic acid metabolism. The growing interest in personalized medicine and precision therapeutics has further increased the relevance of such specialized nucleoside analogs.

The analytical characterization of 1-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,3,4-tetrahydropyrimidine-2,4-dione presents unique challenges due to its polar nature and multiple functional groups. Advanced techniques such as NMR spectroscopy and mass spectrometry are essential for its structural elucidation. Recent advances in computational chemistry have also facilitated the prediction of its physicochemical properties and potential molecular interactions.

In the pharmaceutical industry, there is increasing demand for novel chemical entities with improved selectivity and reduced off-target effects. The structural complexity of this compound offers opportunities for lead optimization in various therapeutic areas. Its potential applications span from antiviral therapies to neurological disorders, reflecting the broad utility of nucleoside analogs in modern medicine.

From a regulatory perspective, compounds like 1-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,3,4-tetrahydropyrimidine-2,4-dione require careful evaluation of their ADME properties (Absorption, Distribution, Metabolism, and Excretion). The presence of multiple hydrophilic groups influences its pharmacokinetic profile, making it an interesting case study for drug formulation specialists. These considerations are particularly relevant given the current emphasis on green chemistry principles in pharmaceutical development.

The compound's potential in bioconjugation strategies is another area of active investigation. Its reactive groups could serve as attachment points for various targeting moieties or imaging probes, making it valuable for theranostic applications. This aligns with the growing trend toward multifunctional pharmaceuticals that combine therapeutic and diagnostic capabilities.

In conclusion, 1-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,3,4-tetrahydropyrimidine-2,4-dione (CAS No. 688007-27-4) represents a fascinating example of modern medicinal chemistry. Its unique structural features and potential biological activities make it a compound of significant interest across multiple scientific disciplines. As research continues to uncover its properties and potential applications, it may well emerge as an important building block for future therapeutic innovations.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)